Tenax Therapeutics (TENX) Preferred Dividend Payments (2013 - 2014)
Tenax Therapeutics (TENX) reported Preferred Dividend Payments of $11.5 million for Q2 2014, up 1105.08% on a YoY basis from $958071.0 in Q2 2013, and up 1153.59% sequentially from -$1.1 million in Q1 2014.
Tenax Therapeutics (TENX) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Tenax Therapeutics (TENX) has 2 years of Preferred Dividend Payments data on file, last reported at $11.5 million in Q2 2014.
- For the quarter ending Q2 2014, Preferred Dividend Payments rose 1105.08% year-over-year to $11.5 million; the trailing twelve-month figure through Jan 2015 stood at $11.5 million (up 341.33% YoY), and the FY2018 full-year result was $7.3 million, changed N/A from the prior year.
- Preferred Dividend Payments grew to $11.5 million in Q2 2014, from -$1.1 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $11.5 million in Q2 2014 to a low of -$2.6 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2014 | 11.55 Mn |
| Jan 31, 2014 | -1.10 Mn |
| Oct 31, 2013 | -2.55 Mn |
| Jul 31, 2013 | -2.09 Mn |
| Apr 30, 2013 | 958,071.00 |